Preventive therapy for tuberculosis in HIV-infected persons: analysis of policy options based on tuberculin status and CD4+ cell count. Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).
Sawert
H
H
World Health Organization, Country Office Thailand, Nonthaburi.
Girardi
E
E
Antonucci
G
G
Raviglione
M C
MC
Viale
P
P
Ippolito
G
G
D017088:AIDS-Related Opportunistic Infections / Q000191:economics* / Q000382:microbiology / Q000517:prevention & control*; D000995:Antitubercular Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D006801:Humans; D007538:Isoniazid / Q000191:economics* / Q000627:therapeutic use; D007558:Italy; D008017:Life Expectancy; D010349:Patient Compliance; D011446:Prospective Studies; D019057:Quality-Adjusted Life Years; D016019:Survival Analysis; D014376:Tuberculosis / Q000191:economics* / Q000209:etiology / Q000517:prevention & control*
D000995:Antitubercular Agents; D007538:Isoniazid